Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine

Mahesh Shrestha, Michael J. Chiu, Robert L. Martin, John J. Cush, Michael S. Wainscott

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Nine consecutive patients presenting with acute gouty arthritis were treated with ketorolac 60 mg Intramuscularly (IM). The average age was 58. Seven were male, and six were black. Pain was quantified in 6 of the patients using a 10-cm visual analog scale that the patients compieted before and 30, 60, and 90 minutes after ketorolac administration. The mean pain score (± standard error of the mean) dropped from 6.43 (±1.25), out of a possible 10, to 1.01 (±.35) (P < .01). There were no side effects of the medication. All of the patients were able to leave the treatment area satisfied with their treatment. None of the patients required crutches at discharge.

Original languageEnglish (US)
Pages (from-to)454-455
Number of pages2
JournalAmerican Journal of Emergency Medicine
Volume12
Issue number4
DOIs
StatePublished - 1994

Fingerprint

Ketorolac Tromethamine
Gouty Arthritis
Ketorolac
Crutches
Therapeutics
Pain
Visual Analog Scale

Keywords

  • Gout
  • gouty arthritis
  • ketorolac
  • pain scale

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine. / Shrestha, Mahesh; Chiu, Michael J.; Martin, Robert L.; Cush, John J.; Wainscott, Michael S.

In: American Journal of Emergency Medicine, Vol. 12, No. 4, 1994, p. 454-455.

Research output: Contribution to journalArticle

Shrestha, Mahesh ; Chiu, Michael J. ; Martin, Robert L. ; Cush, John J. ; Wainscott, Michael S. / Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine. In: American Journal of Emergency Medicine. 1994 ; Vol. 12, No. 4. pp. 454-455.
@article{43c6521fb5f84e029bca2b61c5019182,
title = "Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine",
abstract = "Nine consecutive patients presenting with acute gouty arthritis were treated with ketorolac 60 mg Intramuscularly (IM). The average age was 58. Seven were male, and six were black. Pain was quantified in 6 of the patients using a 10-cm visual analog scale that the patients compieted before and 30, 60, and 90 minutes after ketorolac administration. The mean pain score (± standard error of the mean) dropped from 6.43 (±1.25), out of a possible 10, to 1.01 (±.35) (P < .01). There were no side effects of the medication. All of the patients were able to leave the treatment area satisfied with their treatment. None of the patients required crutches at discharge.",
keywords = "Gout, gouty arthritis, ketorolac, pain scale",
author = "Mahesh Shrestha and Chiu, {Michael J.} and Martin, {Robert L.} and Cush, {John J.} and Wainscott, {Michael S.}",
year = "1994",
doi = "10.1016/0735-6757(94)90061-2",
language = "English (US)",
volume = "12",
pages = "454--455",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine

AU - Shrestha, Mahesh

AU - Chiu, Michael J.

AU - Martin, Robert L.

AU - Cush, John J.

AU - Wainscott, Michael S.

PY - 1994

Y1 - 1994

N2 - Nine consecutive patients presenting with acute gouty arthritis were treated with ketorolac 60 mg Intramuscularly (IM). The average age was 58. Seven were male, and six were black. Pain was quantified in 6 of the patients using a 10-cm visual analog scale that the patients compieted before and 30, 60, and 90 minutes after ketorolac administration. The mean pain score (± standard error of the mean) dropped from 6.43 (±1.25), out of a possible 10, to 1.01 (±.35) (P < .01). There were no side effects of the medication. All of the patients were able to leave the treatment area satisfied with their treatment. None of the patients required crutches at discharge.

AB - Nine consecutive patients presenting with acute gouty arthritis were treated with ketorolac 60 mg Intramuscularly (IM). The average age was 58. Seven were male, and six were black. Pain was quantified in 6 of the patients using a 10-cm visual analog scale that the patients compieted before and 30, 60, and 90 minutes after ketorolac administration. The mean pain score (± standard error of the mean) dropped from 6.43 (±1.25), out of a possible 10, to 1.01 (±.35) (P < .01). There were no side effects of the medication. All of the patients were able to leave the treatment area satisfied with their treatment. None of the patients required crutches at discharge.

KW - Gout

KW - gouty arthritis

KW - ketorolac

KW - pain scale

UR - http://www.scopus.com/inward/record.url?scp=0028308092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028308092&partnerID=8YFLogxK

U2 - 10.1016/0735-6757(94)90061-2

DO - 10.1016/0735-6757(94)90061-2

M3 - Article

C2 - 8031433

AN - SCOPUS:0028308092

VL - 12

SP - 454

EP - 455

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 4

ER -